ICU Medical, Inc. ICUI
NASDAQ · United States · Health Technology
$160.51-2.93 (-1.79%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
ICU Medical has climbed back into positive territory over the past year, yet its longer track record remains mixed, which puts fresh attention on what the current share price asks you to pay for its future cash flows. With the stock closing at US$152.65 most recently, the key issue is whether that tag lines up with what the business can realistically generate over time. Over the past 5 years, ICU Medical shares have fallen 37.1%, which makes the current valuation question more about the...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The global vascular access device market is projected to grow from USD 6.27 billion in 2026 to USD 8.68 billion by 2031, at a 6.7% CAGR. Growth is driven by rising cancer, cardiovascular and kidney disease cases, increased IV therapies and advances in safety-engineered, antimicrobial and ultrasound-guided devices. Peripheral devices and drug administration will see strong growth, while clinics and ambulatory care centers gain adoption. Asia Pacific is forecast to record the highest CAGR. Key pla
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.